Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Condition(s):Multiple SclerosisLast Updated:April 9, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:April 9, 2014Completed
Condition(s):Aortic Aneurysm, ThoracicLast Updated:August 1, 2014Terminated
Condition(s):HealthyLast Updated:January 12, 2024Not yet recruiting
Condition(s):Carotid Artery Diseases; Carotid Atherosclerosis; Carotid Stenosis; Carotid Artery Plaque; Carotid DiseaseLast Updated:May 9, 2022Completed
Condition(s):Diabetic Neuropathy; Cognitive ImpairmentLast Updated:May 4, 2017Completed
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:October 26, 2023Recruiting
Condition(s):Traumatic Brain InjuryLast Updated:August 30, 2017Completed
Condition(s):Post-Op ComplicationLast Updated:July 13, 2020Completed
Condition(s):Parkinson DiseaseLast Updated:August 28, 2018Completed
Condition(s):Huntington’s DiseaseLast Updated:February 1, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.